Recently recovered COVID-19 patients produce varying virus-specific antibodies.

[2greys]

Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, suggests a study published on May 3rd in the journal Immunity, but the responses of different patients are not all the same. While the 14 patients examined in the study showed wide-ranging immune responses, results from the 6 of them that were assessed at two weeks after discharge suggest that antibodies were maintained for at least that long. Additional results from the study indicate which parts of the virus are most effective at triggering these immune responses and should therefore be targeted by potential vaccines.

sciencecodex.com/recently-r...

[Jaybird19]

That is so complicated but all the knowledge gained hopefully will be pooled and taken into account when the vaccine is finally available Too much at stake to have competition between countries and drug companies